Ozempic, Wegovy, other GLP-1RA drugs not linked to increased pancreatic cancer risk, study finds
Posted:
New research has concluded that drugs from the glucagon-like peptide-1 receptor agonists (GLP-1RA) class do not increase the risk of pancreatic cancer.
Wake up smarter with the Circular Ring!
Ready to transform your lifestyle?
Buy now at buff.ly/3JWrlgC and let our ring add some sparkle to your health journey!
Meet Circular team at GIANT Health #GIANT2024 on 9-10 Dec.
Pocketalk Safeguards Student Privacy with COPPA and FERPA-Compliant Translation Technology for K-12 Schools
Pocketalk’s handheld device and Ventana software empower teachers and staff to break language barriers without compromising security.
Beyond COPPA and FERPA, Pocketalk also meets ISO 27001, GDPR,…